BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| bifidobacterium - Oscillospira |
📓
Adhesive <i>Bifidobacterium</i> Induced Changes in Cecal Microbiome Alleviated Constipation in Mice. Frontiers in microbiology (Front Microbiol ) Vol: 10 Issue Pages: 1721 Pub: 2019 Epub: 2019 Aug 13 Authors Wang L , Chen C , Cui S , Lee YK , Wang G , Zhao J , Zhang H , Chen W , Html Article Publication |
| bifidobacterium - Oscillospira |
📓
Exopolysaccharides produced by intestinal Bifidobacterium strains act as fermentable substrates for human intestinal bacteria. Applied and environmental microbiology (Appl Environ Microbiol ) Vol: 74 Issue 15 Pages: 4737-45 Pub: 2008 Aug Epub: 2008 Jun 6 Authors Salazar N , Gueimonde M , Hernández-Barranco AM , Ruas-Madiedo P , de los Reyes-Gavilán CG , Html Article Publication |
| bifidobacterium - Oscillospira |
📓
Therapeutic Effects of Bifidobacterium breve YH68 in Combination with Vancomycin and Metronidazole in a Primary Clostridioides difficile-Infected Mouse Model. Microbiology spectrum (Microbiol Spectr ) Vol: 10 Issue 2 Pages: e0067222 Pub: 2022 Apr 27 Epub: 2022 Mar 21 Authors Yang J , Meng L , Yang H , Html Article Publication |
| bifidobacterium - Oscillospira |
📓
Bifidobacterium pseudocatenulatum Ameliorates DSS-Induced Colitis by Maintaining Intestinal Mechanical Barrier, Blocking Proinflammatory Cytokines, Inhibiting TLR4/NF-?B Signaling, and Altering Gut Microbiota. Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 69 Issue 5 Pages: 1496-1512 Pub: 2021 Feb 10 Epub: 2021 Jan 29 Authors Chen Y , Yang B , Stanton C , Ross RP , Zhao J , Zhang H , Chen W , Publication |
| bifidobacterium - Oscillospira |
📓
Evaluation of the therapeutic effect and dose-effect of Bifidobacterium breve on the primary Clostridioides difficile infected mice. Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 105 Issue 24 Pages: 9243-9260 Pub: 2021 Dec Epub: 2021 Nov 9 Authors Yang J , Yang H , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
